Correlation Between Regenerx Biopharm and Oncology Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regenerx Biopharm and Oncology Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenerx Biopharm and Oncology Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenerx Biopharm In and Oncology Pharma, you can compare the effects of market volatilities on Regenerx Biopharm and Oncology Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenerx Biopharm with a short position of Oncology Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenerx Biopharm and Oncology Pharma.

Diversification Opportunities for Regenerx Biopharm and Oncology Pharma

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Regenerx and Oncology is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Regenerx Biopharm In and Oncology Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncology Pharma and Regenerx Biopharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenerx Biopharm In are associated (or correlated) with Oncology Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncology Pharma has no effect on the direction of Regenerx Biopharm i.e., Regenerx Biopharm and Oncology Pharma go up and down completely randomly.

Pair Corralation between Regenerx Biopharm and Oncology Pharma

If you would invest  0.02  in Oncology Pharma on September 5, 2024 and sell it today you would lose (0.01) from holding Oncology Pharma or give up 50.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy1.75%
ValuesDaily Returns

Regenerx Biopharm In  vs.  Oncology Pharma

 Performance 
       Timeline  
Regenerx Biopharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regenerx Biopharm In has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Regenerx Biopharm is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Oncology Pharma 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Oncology Pharma are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Oncology Pharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Regenerx Biopharm and Oncology Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regenerx Biopharm and Oncology Pharma

The main advantage of trading using opposite Regenerx Biopharm and Oncology Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenerx Biopharm position performs unexpectedly, Oncology Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Pharma will offset losses from the drop in Oncology Pharma's long position.
The idea behind Regenerx Biopharm In and Oncology Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes